Davide Bertuzzo
Asti, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Journal: Journal of neurology
Published: April 02, 2024
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Journal: Journal of neurology
Published: October 03, 2023
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
Journal: European journal of neurology
Published: July 22, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.
Journal: Journal of neurology
Published: March 20, 2022
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study.
Journal: European journal of neurology
Published: November 09, 2021
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report.
Journal: Acta dermato-venereologica
Published: April 13, 2021
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study).
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: August 27, 2020
Droplet Digital PCR Assay for MYD88 L265P : Clinical Applications in Waldenström Macroglobulinemia.
Journal: HemaSphere
Published: August 06, 2019
Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.
Journal: JAMA neurology
Published: July 11, 2017
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: June 16, 2017
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study.
Journal: Muscle & nerve
Published: October 08, 2016
Influence of cigarette smoking on ALS outcome: a population-based study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 17, 2016
Last Updated: 09/26/2026